Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-06-16

European Initiative for Basic Research in Microbiology and Infectious Diseases

Objectif

By initially building a strong coalition among five European centres of excellence, the objectives of EIMID are to reach a critical mass on relevant microbiology topics; to allow rapid and effective scientific reaction to emerging problems; to foster exchange of scientists; to improve the visibility of Microbiology and Infectious Diseases as a discipline of key importance in Europe; to attract the best fellows and post-docs to the area; to counter the current brain drain of young European investigators to USA.

In this context, a consortium will come together, composed of the small Italian company ALTA, the Max Planck Institute for Infection Biology in Berlin, the Centre for Molecular Microbiology and Infection at Imperial College London, the Institut Pasteur in Paris, the Karolinska Institutet in Stockholm, and the vaccine company Chiron in Siena. The consortium will organise a 3-year PhD training programme for fellows who will visit different EIMID centres. Interdisciplinarity and academic-industrial cooperation will be emphasized. Ten fellows will follow an individual training pathway in the areas of host-pathogen interaction and novel strategies for designing vaccines and inhibitors. Parallel training aimed at improving complementary skills will implement the fellows' future role in the global scientific world.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Thème(s)

Appel à propositions

FP6-2004-MOBILITY-2
Voir d’autres projets de cet appel

Régime de financement

EST - Marie Curie actions-Early-stage Training

Coordinateur

ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE S.R.L.
Contribution de l’UE
Aucune donnée
Coût total
Aucune donnée

Participants (6)